1. Home
  2. NEO vs CRI Comparison

NEO vs CRI Comparison

Compare NEO & CRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • CRI
  • Stock Information
  • Founded
  • NEO 2001
  • CRI 1865
  • Country
  • NEO United States
  • CRI United States
  • Employees
  • NEO N/A
  • CRI N/A
  • Industry
  • NEO Precision Instruments
  • CRI Apparel
  • Sector
  • NEO Health Care
  • CRI Consumer Discretionary
  • Exchange
  • NEO Nasdaq
  • CRI Nasdaq
  • Market Cap
  • NEO 2.3B
  • CRI 2.0B
  • IPO Year
  • NEO 1999
  • CRI 2003
  • Fundamental
  • Price
  • NEO $16.53
  • CRI $55.67
  • Analyst Decision
  • NEO Strong Buy
  • CRI Hold
  • Analyst Count
  • NEO 10
  • CRI 6
  • Target Price
  • NEO $20.30
  • CRI $67.67
  • AVG Volume (30 Days)
  • NEO 756.1K
  • CRI 1.4M
  • Earning Date
  • NEO 02-18-2025
  • CRI 10-25-2024
  • Dividend Yield
  • NEO N/A
  • CRI 5.75%
  • EPS Growth
  • NEO N/A
  • CRI 15.51
  • EPS
  • NEO N/A
  • CRI 6.33
  • Revenue
  • NEO $644,118,000.00
  • CRI $2,842,254,000.00
  • Revenue This Year
  • NEO $12.98
  • CRI N/A
  • Revenue Next Year
  • NEO $9.83
  • CRI N/A
  • P/E Ratio
  • NEO N/A
  • CRI $8.79
  • Revenue Growth
  • NEO 12.06
  • CRI N/A
  • 52 Week Low
  • NEO $12.77
  • CRI $50.27
  • 52 Week High
  • NEO $21.22
  • CRI $88.03
  • Technical
  • Relative Strength Index (RSI)
  • NEO 44.50
  • CRI 50.71
  • Support Level
  • NEO $17.24
  • CRI $53.79
  • Resistance Level
  • NEO $18.20
  • CRI $58.13
  • Average True Range (ATR)
  • NEO 0.70
  • CRI 1.71
  • MACD
  • NEO -0.28
  • CRI 0.18
  • Stochastic Oscillator
  • NEO 6.41
  • CRI 50.40

About NEO NeoGenomics Inc.

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of Carter's sales are in the U.S. and through Carter's brand. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

Share on Social Networks: